BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10933148)

  • 1. Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation.
    Cooke KR; Hill GR; Gerbitz A; Kobzik L; Martin TR; Crawford JM; Brewer JP; Ferrara JL
    Transplantation; 2000 Jul; 70(2):272-9. PubMed ID: 10933148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: potential role for a gut-lung axis of inflammation.
    Cooke KR; Hill GR; Gerbitz A; Kobzik L; Martin TR; Crawford JM; Brewer JP; Ferrara JL
    J Immunol; 2000 Dec; 165(11):6612-9. PubMed ID: 11086106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation.
    Cooke KR; Krenger W; Hill G; Martin TR; Kobzik L; Brewer J; Simmons R; Crawford JM; van den Brink MR; Ferrara JL
    Blood; 1998 Oct; 92(7):2571-80. PubMed ID: 9746799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin.
    Cooke KR; Kobzik L; Martin TR; Brewer J; Delmonte J; Crawford JM; Ferrara JL
    Blood; 1996 Oct; 88(8):3230-9. PubMed ID: 8963063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for tumor necrosis factor-alpha-mediated endothelial apoptosis in the development of experimental idiopathic pneumonia syndrome.
    Gerbitz A; Nickoloff BJ; Olkiewicz K; Willmarth NE; Hildebrandt G; Liu C; Kobzik L; Eissner G; Holler E; Ferrara JL; Cooke KR
    Transplantation; 2004 Aug; 78(4):494-502. PubMed ID: 15446306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-derived TNF-alpha regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation.
    Hildebrandt GC; Olkiewicz KM; Corrion LA; Chang Y; Clouthier SG; Liu C; Cooke KR
    Blood; 2004 Jul; 104(2):586-93. PubMed ID: 15069018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation.
    Shankar G; Bryson JS; Jennings CD; Morris PE; Cohen DA
    Am J Respir Cell Mol Biol; 1998 Feb; 18(2):235-42. PubMed ID: 9476911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cell infusion and potentiated by cyclophosphamide.
    Panoskaltsis-Mortari A; Taylor PA; Yaeger TM; Wangensteen OD; Bitterman PB; Ingbar DH; Vallera DA; Blazar BR
    J Clin Invest; 1997 Sep; 100(5):1015-27. PubMed ID: 9276718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical role for CCR2/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation.
    Hildebrandt GC; Duffner UA; Olkiewicz KM; Corrion LA; Willmarth NE; Williams DL; Clouthier SG; Hogaboam CM; Reddy PR; Moore BB; Kuziel WA; Liu C; Yanik G; Cooke KR
    Blood; 2004 Mar; 103(6):2417-26. PubMed ID: 14615370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defibrotide modulates pulmonary endothelial cell activation and protects against lung inflammation in pre-clinical models of LPS-induced lung injury and idiopathic pneumonia syndrome.
    Klein OR; Ktena YP; Pierce E; Fu HH; Haile A; Liu C; Cooke KR
    Front Immunol; 2023; 14():1186422. PubMed ID: 37441074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease.
    Cooke KR; Hill GR; Crawford JM; Bungard D; Brinson YS; Delmonte J; Ferrara JL
    J Clin Invest; 1998 Nov; 102(10):1882-91. PubMed ID: 9819375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for CD54 (intercellular adhesion molecule-1) in leukocyte recruitment to the lung during the development of experimental idiopathic pneumonia syndrome.
    Gerbitz A; Ewing P; Olkiewicz K; Willmarth NE; Williams D; Hildebrandt G; Wilke A; Liu C; Eissner G; Andreesen R; Holler E; Guo R; Ward PA; Cooke KR
    Transplantation; 2005 Mar; 79(5):536-42. PubMed ID: 15753842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous nitric oxide protects against T cell-dependent lethality during graft-versus-host disease and idiopathic pneumonia syndrome.
    Hongo D; Bryson JS; Kaplan AM; Cohen DA
    J Immunol; 2004 Aug; 173(3):1744-56. PubMed ID: 15265904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host disease.
    Ewing P; Miklos S; Olkiewicz KM; Müller G; Andreesen R; Holler E; Cooke KR; Hildebrandt GC
    Exp Hematol; 2007 Jan; 35(1):155-63. PubMed ID: 17198884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
    Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
    Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.
    Cooke KR; Gerbitz A; Crawford JM; Teshima T; Hill GR; Tesolin A; Rossignol DP; Ferrara JL
    J Clin Invest; 2001 Jun; 107(12):1581-9. PubMed ID: 11413166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia.
    Hill GR; Teshima T; Gerbitz A; Pan L; Cooke KR; Brinson YS; Crawford JM; Ferrara JL
    J Clin Invest; 1999 Aug; 104(4):459-67. PubMed ID: 10449438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft-versus-leukemia effect in allogeneic bone marrow transplantation in mice against several radiation-induced leukemias.
    Aizawa S; Sado T; Kamisaku H; Nemoto K; Yoshida K
    Bone Marrow Transplant; 1994 Feb; 13(2):109-14. PubMed ID: 8205078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for transforming growth factor-beta1 in the increased pneumonitis in murine allogeneic bone marrow transplant recipients with graft-versus-host disease after pulmonary herpes simplex virus type 1 infection.
    Adler H; Beland JL; Kozlow W; Del-Pan NC; Kobzik L; Rimm IJ
    Blood; 1998 Oct; 92(7):2581-9. PubMed ID: 9746800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.